Tag: biosimilar market

  • Global Biosimilar Interleukins Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Global Biosimilar Interleukins Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    At What Rate is the Biosimilar Interleukins Market Predicted to Expand Between 2024 and 2033?

    In the recent past, there has been boundless growth in the biosimilar interleukins market. Its size is projected to ascend from $3.9 billion in 2023 to $5.41 billion by 2024, exhibiting a compound annual growth rate (CAGR) of 39.0%. The significant growth experienced in the historical period is associated with the upswing in cases of autoimmune diseases, heightened awareness pertaining to biosimilar interleukins, escalated government backing for biosimilars, enlargement of the biosimilar market, and a surge in patient demand for biosimilars.

    The market size of biosimilar interleukins is anticipated to witness an exponential increase in the coming years. It is projected to expand to a worth of $20.79 billion by 2028, growing at a compound annual growth rate (CAGR) of 40.0%. The escalating growth in the forecasted period can be ascribed to a rising patient demographic, augmented accessibility to healthcare facilities, increasing demands for personalized medicine, and the growing preference for minimally invasive procedures. Key trends projected for the forecast period incorporate developments in biosimilar technologies, targeted immunotherapies, manufacturing and quality control, and global collaboration.

    Claim Your Free Sample of the Global Biosimilar Interleukins Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3433&type=smp

    What Forces Are Boosting the biosimilar interleukins Market’s Growth?

    The growth of the interleukin biosimilars market is anticipated to be fueled by the escalating incidence of autoimmune diseases such as psoriasis and rheumatoid arthritis during the forecast period. Autoimmune disorders occur when immune cells can’t differentiate between healthy cells and potentially harmful antibodies. Biological medications such as anti-interleukin antibodies have demonstrated considerable clinical advantages in controlling cells, and in guiding their proliferation, activation, and migration. As per a 2021 report from Johns Hopkins University, autoimmune diseases impacted roughly 3% of the US population, equating to about 10 million individuals. Hence, the escalating incidence of autoimmune diseases is amplifying the demand for the biosimilar interleukins market, which in turn is anticipated to propel the market’s growth.

    What Key Segments Make Up the Biosimilar Interleukins Market?

    1) By Type: IL-17, IL-23, IL-1, IL-5, IL-6

    2) By Application: Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD), Other Applications

    3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Clinics, Research Institutes

    What Are the Latest Trends Impacting the Biosimilar Interleukins Market?

    Key players in the biosimilar interleukins market are introducing innovative products like Tofidence (tocilizumab-bavi) in an effort to enhance their market profitability. Tofidence is a monoclonal antibody that binds to interleukin-6 receptors and is utilized to address various inflammatory autoimmune conditions. For example, Biogen, a biotech firm based in the US, received FDA approval in September 2023 for Tofidence (tocilizumab-bavi), marking it the first biosimilar to Genentech’s reference Actemra (tocilizumab). Tofidence is delivered via intravenous infusion and has secured approval for the treatment of conditions like severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis.

    Order Now for Fast Delivery of Your Biosimilar Interleukins Market Report!

    https://www.thebusinessresearchcompany.com/report/biosimilar-interleukin-global-market-report

    What Regions Are Dominating the Biosimilar Interleukins Market Growth?

    North America was the largest region in the biosimilar interleukins market in 2023. The regions covered in the biosimilar interleukins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

    The Biosimilar Interleukins Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biosimilar interleukins market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Biosimilar Interleukins Market Include

    1. Biosimilar Interleukins Market Executive Summary

    2. Biosimilar Interleukins Market Segments

    3. Biosimilar Interleukins Market Size And Template Market Growth Rate

    4. Key Biosimilar Interleukins Market Trends

    5. Major Biosimilar Interleukins Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Biosimilar Interleukins Market

    26. Top Biosimilar Interleukins Companies

    27. Biosimilar Interleukins Market Opportunities And Strategies

    28. Biosimilar Interleukins Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Generic Pharmaceuticals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

    Biosimilars Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

    Oncology Biosimilars Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Takeaways From The Biosimilar Interleukins Market Overview 2024

    5 Takeaways From The Biosimilar Interleukins Market Overview 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Biosimilar Interleukins Global Market Report 2024, the biosimilar interleukins market is expected to show promising growth in the forecast period.

    The biosimilar interleukins market has experienced exponential growth in recent years, driven by various factors contributing to its remarkable expansion. Let’s delve into the trends, innovations, and market dynamics shaping the landscape of biosimilar interleukins.

    Surging Autoimmune Diseases Propel Market Growth

    • Prevalence of Autoimmune Diseases: Conditions like psoriasis and rheumatoid arthritis are driving demand for interleukin biosimilars.
    • Clinical Benefits: Interleukin-targeting biologic drugs have demonstrated significant clinical benefits in regulating immune cells, addressing proliferation, activation, and migration issues.
    • Growing Patient Population: Approximately 3% of the US population suffers from autoimmune diseases, highlighting the substantial demand for biosimilar interleukins.

    Key Players Driving Innovation and Market Expansion

    • Industry Leaders: Major companies like Biogen, Mabpharm Limited, and Gedeon Richter PLC are driving innovation in the biosimilar interleukins market.
    • Innovative Products: Biogen’s Tofidence (tocilizumab-bavi) stands as an innovative biologic treatment targeting interleukin-6 receptors, approved for various inflammatory autoimmune disorders.

    View More On The Biosimilar Interleukins Market Report 2024 – https://www.thebusinessresearchcompany.com/report/biosimilar-interleukin-global-market-report

    Strategic Acquisitions and Expansion Efforts

    • Equillium’s Acquisition: Equillium’s acquisition of Bioniz Therapeutics Inc. in February 2022 expands its portfolio of immunomodulatory drug candidates, strengthening its position in the market.
    • Market Expansion: Such strategic moves enable companies to broaden their product offerings and enhance their competitive edge in the rapidly evolving biosimilar interleukins market.

    Market Segmentation and Regional Influence

    • Segmentation: The biosimilar interleukins market is segmented by type (IL-17, IL-23, IL-1, etc.), application (psoriasis, rheumatoid arthritis, asthma, etc.), and distribution channel.
    • Regional Dominance: North America emerged as the largest region in the biosimilar interleukins market in 2023, reflecting the region’s significant contributions to market growth and innovation.

    Future Trends and Growth Projections

    • Market Projections: The market is expected to reach $20.79 billion by 2028, driven by factors like increased access to healthcare and growing demand for personalized medicine.
    • Innovative Trends: Advances in biosimilar technology, targeted immunotherapies, and quality control are expected to shape the future of the biosimilar interleukins market.

    In conclusion, the biosimilar interleukins market is witnessing unprecedented growth fueled by rising autoimmune diseases, technological innovations, and strategic initiatives by key industry players. As demand for effective treatments for autoimmune disorders continues to escalate, the biosimilar interleukins market is poised to embrace novel solutions and technologies, ushering in a new era of healthcare innovation and patient care.

    Request A Sample Of The Global Biosimilar Interleukins Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=3433&type=smp